Signal2026-07-16
ClinicalTrials.gov

[PHASE2] Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

Part of

Cancer Immunotherapy And Combination Strategies

Open primary sourceSee the whole picture